Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The relationship between the use of Δ-9-tetrahydrocannabinol and the cannabinoid vaping in French student vapers: An exploratory mixed-methods study.

Created on 20 Sep 2026

Authors

Shérazade Kinouani, Maximilien Simon, Christophe Tzourio

Published in

L'Encephale. Sep 19, 2026. Epub Sep 19, 2026.

Abstract

There is little data on vaping non-nicotine substances (NNS vaping) among young adults, its relationship with other methods of consuming cannabinoids, or how this practice is perceived in France. Our research aimed to: (i) measure the association between Δ-9-tetrahydrocannabinol (THC) use in the past 12 months and NNS vaping; (ii) describe THC and cannabidiol (CBD) vaping; and (iii) explore reasons for, and barriers to, THC and CBD vaping.
We led explanatory sequential research in a French university, combining data from a cross-sectional sub-study among current vapers and a qualitative sub-study among daily vapers.
Among the 206 student vapers of the quantitative sub-study (median age: 21, men: 60.5%), 11 of whom reported NNS vaping with a predominance of THC or CBD vaping. After adjustment, no significant association was found between THC use in the past 12 months and NNS vaping (aOR=2.29, 95% CI: 0.23-22.37). The qualitative sub-study had 30 participants (median age: 21.5, men: 57%). They did not regularly vape cannabinoids and were largely unaware of this practice. Some intrinsic and extrinsic factors influencing cannabinoid vaping were identified as either facilitators or barriers to the practice. Cannabinoid vaping was perceived as appealing primarily among heavy THC consumers.
In this exploratory study the cannabinoid vaping was uncommon among student vapers and had not become the norm. Further research is necessary to understand cannabinoid vaping practices, particularly in the event of changes to French THC and CBD regulations.

PMID:
42763250
Bibliographic data and abstract were imported from PubMed on 20 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement